GRAL vs ABBV: Which Stock is Better?
Side-by-side comparison of GRAIL, LLC and Abbvie Inc in 2026
GRAL
GRAIL, LLC
$101.31
ABBV
Abbvie Inc
$214.04
Key Metrics Comparison
| Metric | GRAL | ABBV | Winner |
|---|---|---|---|
| Market Cap | $3.95B | $378.29B | ABBV |
| P/E Ratio | N/A | 160.93 | ABBV |
| EPS (TTM) | $N/A | $1.33 | ABBV |
| Revenue Growth | 0.3% | 0.1% | GRAL |
| Gross Margin | -47.5% | 71.5% | ABBV |
Analyze GRAL
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GRAL or ABBV a better investment?
Comparing GRAL and ABBV: GRAIL, LLC has a market cap of $3.95B while Abbvie Inc has $378.29B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GRAL and ABBV?
GRAL (GRAIL, LLC) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GRAL or ABBV?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GRAL or ABBV?
GRAL has higher revenue growth at 0.3% vs 0.1% for ABBV.
Which company is more profitable: GRAL or ABBV?
Abbvie Inc (ABBV) has higher gross margins at 71.5% compared to -47.5% for GRAL.
Which is the larger company: GRAL or ABBV?
Abbvie Inc (ABBV) is larger with a market cap of $378.29B compared to $3.95B for GRAL.
Should I buy GRAL or ABBV in 2026?
Both GRAL and ABBV have investment merit. GRAL trades at $101.31 while ABBV trades at $214.04. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GRAL and ABBV stock?
Key differences: Market Cap ($3.95B vs $378.29B), P/E Ratio (N/A vs 160.9x), Revenue Growth (0.3% vs 0.1%), Gross Margin (-47.5% vs 71.5%).